Skip to main content
Equibles

BWAY · Brainsway Ltd.

Track BWAY — free

Use BWAY with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BWAY.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$12.65 -0.55 (-4.17%)
Rebalance outlook locked
Market Cap
$542.61M
Shares
40.25M
Volume · Oct 1 99.68K Avg daily vol (3M) 115.56K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$13.20 Open$13.56 Day$13.17–13.84 52W close$7.25–17.17 Avg vol 30d84K Short int200K · 0.5% float · 2.2d Short vol43% Last earningsAug 12, 2026 DataJan 2020–Sep 2026

Up next

Next earnings call
Nov 11, 2026 Est · unconfirmed · in 6 wks
Q4 2025 earnings call transcript
call held Mar 11, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
+27.3%
Year over year
Operating margin
8.3%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+4.1%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
0.5%
Latest settlement · 2.2 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Neutral Momentum Weak Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 16.3 · calm Equity put/call 0.53
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg −4%
below
Price vs 50-day avg −10%
below
RSI (14) 37
neutral
MACD trend Positive
52-week position 60%
mid-range
Momentum
relative strength
Weak
1-month return −8%
trailing
6-month return −8%
trailing
YTD return +39%
this year
Relative strength −20%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $15 › 200d $14 — 50d above 200d
Institutional flow Distributing
-2% holders QoQ · +7 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.50% of float · ▼ -4.1% MoM · 2.2 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
55 holders — near 3-yr high, broad support
Squeeze score 32
low risk · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 52%
annualized · 1-yr
Max drawdown −23%
past year
ATR 4.8%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Mar 31, 2026
Revenue · full year 2026 Initiated $66M – $68M

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral
1 · 4 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−4% Neutral
Price vs 50-day avg
−10% Bearish
RSI (14)
37 Neutral
MACD trend
Positive Bullish
52-week position
60% Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $15 › 200d $14 — 50d above 200d
Institutional flow Distributing
-2% holders QoQ · +7 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.50% of float · ▼ -4.1% MoM · 2.2 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
55 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $7 Now $13 · 60% Range high $17
vs 200-day avg -4% vs 50-day avg -10%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Medical Devices — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
BWAY
Brainsway Ltd.
this stock
$542.61M — — — 0.5%
ABT
Abbott Laboratories
 $174.90B -21.1% +5.7% 28.1 1.1%
MDT
Medtronic plc
 $113.38B -10.2% +8.4% 21.8 1.3%
SYK
Stryker Corp
 $104.47B -21.6% +11.2% 28.2 2.0%
BSX
Boston Scientific Corp
 $63.59B -54.2% +12.5% 17.8 3.2%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
55
% held
28.4%
Net QoQ
-294.8K sh
Top holder
Valor Management LLC
Held Float
View
Held by Funds
Fund positions
14
View
Short & Settlement
Short Interest Falling
Shares short
199.6K
Days to cover
2.2d
Change
-8.5K sh
View
Short Volume
Short vol %
43%
As of
Sep 30, 2026
Short Total
View
Fails to Deliver
FTD shares
386
Value
$5.5K
As of
Sep 2, 2026
View
Off-Exchange
Off-exchange %
38.6%
Week of
Aug 24, 2026
Off-exch Lit
View
Filings
SEC Filings
Latest
6-K
Filed
Sep 29, 2026
This year
27
View
Exempt Offerings
Offering
$20.0M
Filed
Oct 15, 2024
View
Earnings & Events
Earnings Calls Upcoming
Next call
Oct 17, 2026
Last call
Sep 26, 2026
View
Investor Relations
Upcoming events
2
View

Performance

5D 20D 120D MTD YTD
BWAY -1.9% -7.5% -7.7% -9.1% +38.8%
SPY -0.7% +0.1% +12.2% -0.6% +11.8%
vs SPY -1.2% -7.6% -19.9% -8.5% +27.0%
Key facts CIK 1505065 CUSIP 10501L106 13F (30d) 1 filings 1 filers Visit website Investor relations